Form 4 for ACRS Aclaris Therapeutics, Inc.
Accepted 2022-01-05 00:00:00 ET · period of report 2022-01-03 · accession 0001209191-22-001712 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-01-05 | 2022-01-03 | ACRS | Ali-Jackson Kamil | CLO | M - OptEx | — | +45.5K | 160.2K | +40% | — |
| DM | 2022-01-05 | 2022-01-03 | ACRS | Ali-Jackson Kamil | CLO | M - OptEx | $0.00 | -45.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-03 | M | A | 3,875 | — | 118,571 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. |
| 2 | Common | Common Stock | 2022-01-03 | M | A | 6,638 | — | 153,114 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. |
| 3 | Common | Common Stock | 2022-01-03 | M | A | 27,905 | — | 146,476 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. |
| 4 | Common | Common Stock | 2022-01-03 | M | A | 7,100 | — | 160,214 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. |
| 5 | Derivative | Restricted Stock Unit | 2022-01-03 | M | D | 6,638 | $0.00 | 0 | D | — · — to — | 19,914 Common Stock | (F2) Represents the number of restricted stock units that were accelerated by mutual agreement between the Reporting Person and the Issuer. The balance of unvested restricted stock units, if any, were forfeited. (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. (F5) The shares underlying these restricted stock units vest in four equal annual installments beginning on March 2, 2021, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. |
| 6 | Derivative | Restricted Stock Units | 2022-01-03 | M | D | 27,905 | $0.00 | 0 | D | — · — to — | 34,350 Common Stock | (F2) Represents the number of restricted stock units that were accelerated by mutual agreement between the Reporting Person and the Issuer. The balance of unvested restricted stock units, if any, were forfeited. (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. (F4) The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2020, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. |
| 7 | Derivative | Restricted Stock Units | 2022-01-03 | M | D | 7,100 | $0.00 | 0 | D | — · — to — | 28,400 Common Stock | (F2) Represents the number of restricted stock units that were accelerated by mutual agreement between the Reporting Person and the Issuer. The balance of unvested restricted stock units, if any, were forfeited. (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. (F6) The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2022, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. |
| 8 | Derivative | Restricted Stock Units | 2022-01-03 | M | D | 3,875 | $0.00 | 0 | D | — · — to — | 3,875 Common Stock | (F2) Represents the number of restricted stock units that were accelerated by mutual agreement between the Reporting Person and the Issuer. The balance of unvested restricted stock units, if any, were forfeited. (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. (F3) The shares underlying these restricted stock units vest in four equal annual installments beginning on February 1, 2019, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. |